MAPT and Alzheimer disease: Moreover, elevations of p-PERK, p-IRE1, and p-eIF2α in human AD were demonstrated to be brain-area dependent [34], associated with abnormally phosphorylated Tau [30,34,35], and likely more involved at the early stages of AD pathology [7,30].